Anavex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. 

CEO
Christopher U. Missling
CEOChristopher U. Missling
Employees
42
Employees42
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2004
Founded2004
Employees
42
Employees42

AVXL Key Statistics

Market cap
804.83M
Market cap804.83M
Price-Earnings ratio
-16.54
Price-Earnings ratio-16.54
Dividend yield
Dividend yield
Average volume
1.17M
Average volume1.17M
High today
$9.75
High today$9.75
Low today
$9.33
Low today$9.33
Open price
$9.52
Open price$9.52
Volume
717.07K
Volume717.07K
52 Week high
$14.44
52 Week high$14.44
52 Week low
$5.03
52 Week low$5.03

AVXL News

TipRanks 4d
Promising Clinical Data and Market Potential Drive Buy Rating for Anavex Life Sciences

Anavex Life Sciences, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy r...

TipRanks 5d
Anavex announces latest findings for blarcamesine

Anavex (AVXL) Life Sciences announced the latest findings for blarcamesine, an oral small molecule for the potential treatment of early Alzheimer’s disease, AD....

People also own

Based on the portfolios of people who own AVXL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.